Pomdoctor Limited (POM)

NASDAQ: POM · Real-Time Price · USD
4.350
-0.420 (-8.81%)
At close: Oct 10, 2025, 4:00 PM EDT
4.230
-0.120 (-2.76%)
After-hours: Oct 10, 2025, 7:59 PM EDT
-8.81%
Market Cap515.22M
Revenue (ttm)46.93M
Net Income (ttm)-19.64M
Shares Out 118.44M
EPS (ttm)-0.52
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,203,945
Open4.890
Previous Close4.770
Day's Range4.110 - 4.891
52-Week Range3.470 - 5.040
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About POM

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company’s business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other he... [Read more]

Sector Healthcare
IPO Date Oct 8, 2025
Employees 156
Stock Exchange NASDAQ
Ticker Symbol POM
Full Company Profile

Financial Performance

In 2024, Pomdoctor's revenue was 342.56 million, an increase of 12.37% compared to the previous year's 304.85 million. Losses were -143.36 million, -1.40% less than in 2023.

Financial numbers in CNY Financial Statements

News

U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown

Six IPOs debuted this week, while two SPACs listed. Thirteen IPOs and five SPACs also submitted initial filings. No traditional IPOs are currently scheduled for the week ahead as the government shutdo...

16 hours ago - Seeking Alpha

POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option

GUANGZHOU, China , Oct. 10, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announc...

23 hours ago - PRNewsWire

PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules

The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 million

1 day ago - Benzinga

POMDOCTOR LIMITED Announces Closing of Initial Public Offering

GUANGZHOU, China , Oct. 9, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announce...

2 days ago - PRNewsWire

POMDOCTOR LIMITED Announces Pricing of Initial Public Offering

GUANGZHOU, China , Oct. 8, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the pricing ...

3 days ago - PRNewsWire

PomDoctor Files For Nasdaq IPO That May Be Overvalued

The online health services provider aims to raise up to $30 million through a Nasdaq listing, even as its liabilities far outweigh its assets

2 months ago - Benzinga

PomDoctor Begins $15 Million U.S. IPO Rollout

PomDoctor Limited is raising $15 million in an IPO to expand its telehealth platform in China. The telehealth sector is expected to grow substantially in the coming year in China. However, POM faces i...

7 months ago - Seeking Alpha

Chinese online medical platform PomDoctor files for a $15 million US IPO

PomDoctor, an online platform in China offering chronic disease management services, filed on Thursday with the SEC to raise up to $15 million in an initial public offering.

7 months ago - Renaissance Capital

Pomdoctor IPO Registration Document (F-1)

Pomdoctor has filed to go public with an IPO on the NASDAQ.

7 months ago - SEC